JPMorgan has shared a list of 100 stocks it sees outperforming the market in times when inflationary fears and expectations are rising.
FDA backs changing Covid booster shots to target most recent omicron subvariants
There hasn't been enough research on how much protection a fourth dose can offer, medical professionals told CNBC. Justin Sullivan...
Read more